Caris Life Sciences Prices IPO at $21 Per Share

Jun 18, 2025
Caris Life Sciences has announced the pricing of its initial public offering at $21 per share, with shares expected to trade on Nasdaq under the symbol 'CAI'.
Caris Life Sciences Prices IPO at $21 Per Share

Caris Life Sciences has announced the pricing of its initial public offering (IPO) at $21.00 per share, announced in a press release. The company is offering 23,529,412 shares of its common stock, with an additional option for underwriters to purchase up to 3,529,411 more shares. Trading is set to begin on June 18, 2025, on the Nasdaq Global Select Market under the ticker symbol 'CAI'.

The IPO is expected to close on June 20, 2025, subject to customary closing conditions. BofA Securities, J.P. Morgan, and Goldman Sachs & Co. LLC are leading the book-running management, with Citigroup, TD Cowen, Evercore ISI, and Guggenheim Securities also participating as book-running managers. BTIG and Wolfe | Nomura Alliance are acting as co-managers for the offering.

We hope you enjoyed this article

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.